Population Screening for Colorectal Cancer Means Getting FIT: The Past, Present, and Future of Colorectal Cancer Screening Using the Fecal Immunochemical Test for Hemoglobin (FIT)

被引:143
作者
Allison, James E. [1 ,2 ]
Fraser, Callum G. [3 ]
Halloran, Stephen P. [4 ,5 ]
Young, Graeme P. [6 ]
机构
[1] Univ Calif San Francisco, Sch Med, Div Gastroenterol, San Francisco, CA 94110 USA
[2] Kaiser Permanente No Calif, Div Res, Oakland, CA USA
[3] Univ Dundee, Ctr Res Canc Prevent & Screening, Sch Med, Dundee, Scotland
[4] Royal Surrey Cty Hosp, NHS Bowel Canc Screening Southern Programme Hub, Guildford, Surrey, England
[5] Univ Surrey, Guildford GU2 5XH, Surrey, England
[6] Flinders Univ S Australia, Flinders Ctr Innovat Canc, Bedford Pk, SA 5042, Australia
关键词
Population screening; Colorectal cancer; Fecal immunochemical test for hemoglobin; Colorectal cancer screening; OCCULT-BLOOD-TESTS; RANDOMIZED CONTROLLED-TRIAL; AMERICAN-COLLEGE; PARTICIPATION; RISK; COLONOSCOPY; PERFORMANCE; SIGMOIDOSCOPY; MORTALITY; IMPROVES;
D O I
10.5009/gnl.2014.8.2.117
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
Fecal immunochemical tests for hemoglobin (FIT) are changing the manner in which colorectal cancer (CRC) is screened. Although these tests are being performed worldwide, why is this test different from its predecessors? What evidence supports its adoption? How can this evidence best be used? This review addresses these questions and provides an understanding of FIT theory and practices to expedite international efforts to implement the use of FIT in CRC screening.
引用
收藏
页码:117 / 130
页数:14
相关论文
共 86 条
  • [21] Quantitation of Hemoglobin Improves Fecal Immunochemical Tests for Noninvasive Screening
    Fraser, Callum G.
    Allison, James E.
    Young, Graeme P.
    Halloran, Stephen P.
    [J]. CLINICAL GASTROENTEROLOGY AND HEPATOLOGY, 2013, 11 (07) : 839 - 840
  • [22] A future for faecal haemoglobin measurements in the medical laboratory
    Fraser, Callum G.
    [J]. ANNALS OF CLINICAL BIOCHEMISTRY, 2012, 49 : 518 - 526
  • [23] A Proposal to Standardize Reporting Units for Fecal Immunochemical Tests for Hemoglobin
    Fraser, Callum G.
    Allison, James E.
    Halloran, Stephen P.
    Young, Graeme P.
    [J]. JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE, 2012, 104 (11): : 810 - 814
  • [24] Newer Fecal Tests: Opportunities for Professionals in Laboratory Medicine
    Fraser, Callum G.
    Allison, James E.
    Young, Graeme P.
    Halloran, Stephen P.
    [J]. CLINICAL CHEMISTRY, 2012, 58 (06) : 963 - 965
  • [25] Fraser CG, 2013, CLIN CHEM LAB MED, P1
  • [26] Influence of seasonal variations in ambient temperatures on performance of immunochemical faecal occult blood test for colorectal cancer screening: observational study from the Florence district
    Grazzini, Grazia
    Ventura, Leonardo
    Zappa, Marco
    Ciatto, Stefano
    Confortini, Massimo
    Rapi, Stefano
    Rubeca, Tiziana
    Visioli, Carmen Beatriz
    Halloran, Stephen P.
    [J]. GUT, 2010, 59 (11) : 1511 - 1515
  • [27] European guidelines for quality assurance in colorectal cancer screening and diagnosis. First Edition Faecal occult blood testing
    Halloran, S. P.
    Launoy, G.
    Zappa, M.
    [J]. ENDOSCOPY, 2012, 44 : SE65 - SE87
  • [28] Randomised controlled trial of faecal-occult-blood screening for colorectal cancer
    Hardcastle, JD
    Chamberlain, JO
    Robinson, MHE
    Moss, SM
    Amar, SS
    Balfour, TW
    James, PD
    Mangham, CM
    [J]. LANCET, 1996, 348 (9040) : 1472 - 1477
  • [29] Primary care endorsement letter and a patient leaflet to improve participation in colorectal cancer screening: results of a factorial randomised trial
    Hewitson, P.
    Ward, A. M.
    Heneghan, C.
    Halloran, S. P.
    Mant, D.
    [J]. BRITISH JOURNAL OF CANCER, 2011, 105 (04) : 475 - 480
  • [30] Risk of colorectal cancer seven years after flexible sigmoidoscopy screening: randomised controlled trial
    Hoff, Geir
    Grotmol, Tom
    Skovlund, Eva
    Bretthauer, Michael
    [J]. BMJ-BRITISH MEDICAL JOURNAL, 2009, 338 : 1363 - 1365